Overview Efficacy of Ramelteon in Adults With Chronic Insomnia Status: Terminated Trial end date: 2005-08-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate subjectively reported treatment effects of ramelteon, once daily (QD), in adults with chronic insomnia. Phase: Phase 3 Details Lead Sponsor: Takeda